Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gestational Diabetes and Pharmacotherapy (GAP)
NCT03527537Phase 4Active, not recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- May 2021
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin in gestational diabetes mellitus (GDM), sponsored by Medical College of Wisconsin. Started May 2021; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT03527537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527537.